Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Greenwich LifeSciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GLSI
Nasdaq
2836
greenwichlifesciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Greenwich LifeSciences, Inc.
3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets
- Sep 15th, 2026 8:51 pm
Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027
- Aug 10th, 2026 4:00 am
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
- Jul 22nd, 2026 4:00 am
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
- Jul 20th, 2026 4:00 am
Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
- Jul 16th, 2026 5:30 am
Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
- Jul 9th, 2026 4:00 am
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
- Jun 1st, 2026 6:15 am
GLSI Stock Climbs After Removing A Key Overhang – Retail Turns Focus To High-Stakes Breast Cancer Trial
- Jun 1st, 2026 5:48 am
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
- Jun 1st, 2026 4:00 am
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
- May 22nd, 2026 2:30 pm
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
- Apr 23rd, 2026 4:00 am
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
- Apr 20th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Financing Strategy
- Apr 14th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
- Apr 7th, 2026 4:00 am
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
- Mar 19th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting
- Mar 18th, 2026 4:00 am
Scroll